研究组合疗法作为一种提高抗微生物活性和重新利用抗微生物药物的手段
1Division of Infection and Global Health, University of St Andrews, St Andrews, Scotland, UK. rjhh@st-andrews.ac.uk.
Methods in molecular biology (Clifton, N.J.)
|July 1, 2024
概括
使用多种抗生素的组合疗法提供了一种有希望的策略,以打击不断上升的抗菌素耐药性 (AMR). 这种方法可以有效地治疗感染,并防止未来耐药细菌的发展.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 目前的临床实践依赖于单抗生素治疗,由于耐药性感染的增加,这些治疗越来越失败.
- 多抗药性,广泛抗药性和无法治疗的感染的出现构成了全球重大健康挑战.
- 抗菌素耐药性 (AMR) 危机需要超越传统单一治疗的新型治疗策略.
研究的目的:
- 探索组合疗法的潜力,以解决日益严重的AMR危机.
- 将组合疗法作为一种可行的策略,用于治疗易受感染和耐药感染.
- 突出结合疗法的作用,防止新的抗菌素耐药性的出现.
主要方法:
- 总结抗生素联合治疗的理论基础.
- 审查用于评估组合疗法的标准体外方法.
- 分析药物组合对抗性演变的影响.
主要成果:
- 组合疗法中的每一种额外的抗生素都会使病原体耐药性的可能性呈指数级下降.
- 组合疗法可以通过在协同尾酒中使用旧的通用抗生素来恢复其疗效.
- 这种方法为克服耐药病原体引起的感染提供了潜在的途径.
结论:
- 组合疗法是打击抗菌素耐药性危机和确保抗菌剂持续有效性的强大策略.
- 抗生素的协同使用可以治疗现有的耐药性感染,并减轻未来耐药性的发展.
- 这种方法可以恢复以前未被充分利用或无效的抗菌化合物的实用性.
相关概念视频
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Antibiotic Selection
53.0K
Overview
53.0K
Combined Effects of Drugs: Antagonism
8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K
Antidotes
626
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
626


